Results 71 to 80 of about 1,501,058 (128)

Lithium in Bipolar Disorder: Renal Mechanisms, Nephrotoxicity Phenotypes, and a Shared-Care Pathway for Clinical Practice. [PDF]

Int J Mol Sci
Rijavec N, Večerić-Haler Ž.
europepmc   +1 more source

Efficient Opinion Sharing in Large Decentralised Teams

, 2012
In this paper we present an approach for improving the accuracy of shared opinions in a large decentralised team. Specifically, our solution optimises the opinion sharing process in order to help the majority of agents to form the correct opinion about a
Jennings, Nick, Pryymak, O, Rogers, A, Rogers, Alex, Jennings, N, Pryymak, Oleksandr   +5 more
core  

Lithium Dispensing Patterns in Dutch Youth: Prevalence, Incidence Dosages, and Duration of Use From 2011 to 2022. [PDF]

Bipolar Disord
Gangapersad RN, Ringeling LT, Bos JHJ, Koch BCP, Hillegers MHJ, Garcia-Gomez P, Schuiling-Veninga CCM, Hak E, Dierckx B.   +8 more
europepmc   +1 more source

Correlation Analysis of Blood Lithium Metabolism Kinetics and Concentration-to-Dose Ratio in Patients With Hypertension and Manic Episodes. [PDF]

Hum Psychopharmacol
Liao D, Li M, Xiong Z, Ji Q, Xia Y, Liu B, Gui X.   +6 more
europepmc   +1 more source

Reconceptualizing bipolar disorder through an integrative biological lens: synthesis, convergence, and emerging directions. [PDF]

Front Integr Neurosci
Muhammad YA.
europepmc   +1 more source

Lithium for depression-related hospitalisation in bipolar disorder. [PDF]

Lancet Psychiatry
Singh B.
europepmc   +1 more source

Cytotoxic Lesion of the Corpus Callosum in a Patient with Acute-on-chronic Lithium Toxicity. [PDF]

Intern Med
Miura T, Kuroshita T, Higuchi Y, Ohno M, Notsuyu A, Fushino T, Ono T, Tomisawa N, Boku K, Enomoto Y, Inoue Y.   +10 more
europepmc   +1 more source

Pharmacological maintenance treatment in older age bipolar disorder. [PDF]

Curr Opin Psychiatry
Zittema D, Dols A.
europepmc   +1 more source

Pharmacological Management, Safety, and Outcomes in Bipolar Disorder: An Integrated Narrative Review of Clinical and Translational Evidence. [PDF]

Neuropsychopharmacol Rep
Bereda G.
europepmc   +1 more source

Catatonia treatments and risk of recurrence. [PDF]

J Affect Disord
Patarroyo-Rodriguez L, Duque L, Pazdernick VK, Burson JR, Singh B.   +4 more
europepmc   +1 more source